United States (US) Reproductive Health Devices Market Outlook to 2033: Assisted Reproductive Technology (ART) Devices, Reversible Contraceptive Devices and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report Download FREE Resources

Published: June 23, 2025 Report Code: GDME0836MDB-ST

Select Item

GlobalData’s “United States Reproductive Health Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Reproductive Health Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Reversible Contraceptive Devices, Endometrial Ablation Devices, Assisted Reproductive Technology (ART) Devices and Female Sterilization Devices

The United States Reproductive Health Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Reproductive Health Devices Market.
• Global corporate-level profiles of key companies operating within the United States Reproductive Health Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Reproductive Health Devices is segmented as follows – _x000D_

• Reversible Contraceptive Devices_x000D_

• Endometrial Ablation Devices_x000D_

• Assisted Reproductive Technology (ART) Devices_x000D_

• Female Sterilization Devices

Reasons to Buy

The United States Reproductive Health Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Bayer AG_x000D_
Organon_x000D_
CooperSurgical Inc_x000D_
Hologic Inc_x000D_
Allergan Aesthetics_x000D_
Cook Medical LLC_x000D_
Vitrolife AB_x000D_
FUJIFILM Irvine Scientific Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Reproductive Health Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 10

3 Reproductive Health Devices Market, United States 14

3.1 Reproductive Health Devices Market, United States, Revenue ($m), 2018-2033 14

3.2 Reproductive Health Devices Market, United States, Revenue Mix ($m), 2023 16

3.3 Reproductive Health Devices Market, United States, Category Contribution by Revenue ($m), 2023 17

3.4 Reproductive Health Devices Market, United States, Revenue ($m), 2018-2033 19

3.5 Reproductive Health Devices Market, United States, Volume (Units), 2018-2033 21

3.6 Reproductive Health Devices Market, United States, Volume (Units), 2018-2033 23

3.7 Reproductive Health Devices Market, United States, Company Share by Revenue ($m), 2023 26

4 Assisted Reproductive Technology (ART) Devices Market, United States 28

4.1 Assisted Reproductive Technology (ART) Devices Market, United States, Revenue Mix ($m), 2023 28

4.2 Assisted Reproductive Technology (ART) Devices Market, United States, Segment Contribution (%), 2023 29

4.3 Assisted Reproductive Technology (ART) Devices Market, United States, Revenue ($m), 2018-2033 31

4.3.1 ART Media Market, United States, Revenue ($m), by Segment, 2018-2033 33

4.3.2 ART Micropipettes Market, United States, Revenue ($m), by Segment, 2018-2033 35

4.4 Assisted Reproductive Technology (ART) Devices Market, United States, Volume (Units), 2018-2033 37

4.4.1 ART Media Market, United States, Volume (Units), by Segment, 2018-2033 40

4.4.2 ART Micropipettes Market, United States, Volume (Units), by Segment, 2018-2033 43

4.5 Assisted Reproductive Technology (ART) Devices Market, United States, Average Price ($), 2018-2033 45

4.6 Assisted Reproductive Technology (ART) Devices Market, United States, Distribution Share by Revenue ($m), 2018-2033 47

4.7 Assisted Reproductive Technology (ART) Devices Market, United States, Company Share by Revenue ($m), 2023 48

5 Endometrial Ablation Devices Market, United States 50

5.1 Endometrial Ablation Devices Market, United States, Revenue Mix ($m), 2023 50

5.2 Endometrial Ablation Devices Market, United States, Segment Contribution (%), 2023 51

5.3 Endometrial Ablation Devices Market, United States, Revenue ($m), 2018-2033 53

5.4 Endometrial Ablation Devices Market, United States, Volume (Units), 2018-2033 55

5.5 Endometrial Ablation Devices Market, United States, Average Price ($), 2018-2033 57

5.6 Endometrial Ablation Devices Market, United States, Distribution Share by Revenue ($m), 2018-2033 58

5.7 Endometrial Ablation Devices Market, United States, Company Share by Revenue ($m), 2023 59

6 Female Sterilization Devices Market, United States 61

6.1 Female Sterilization Devices Market, United States, Revenue Mix ($m), 2023 61

6.2 Female Sterilization Devices Market, United States, Segment Contribution (%), 2023 62

6.3 Female Sterilization Devices Market, United States, Revenue ($m), 2018-2033 64

6.4 Female Sterilization Devices Market, United States, Volume (Units), 2018-2033 66

6.5 Female Sterilization Devices Market, United States, Average Price ($), 2018-203 68

6.6 Female Sterilization Devices Market, United States, Distribution Share by Revenue ($m), 2018-2033 69

6.7 Female Sterilization Devices Market, United States, Company Share by Revenue ($m), 2023 70

7 Reversible Contraceptive Devices Market, United States 72

7.1 Reversible Contraceptive Devices Market, United States, Revenue Mix ($m), 2023 72

7.2 Reversible Contraceptive Devices Market, United States, Segment Contribution (%), 2023 73

7.3 Reversible Contraceptive Devices Market, United States, Revenue ($m), 2018-2033 75

7.3.1 Intrauterine Devices (IUDs) Market, United States, Revenue ($m), by Segment, 2018-2033 77

7.4 Reversible Contraceptive Devices Market, United States, Volume (Units), 2018-2033 79

7.4.1 Intrauterine Devices (IUDs) Market, United States, Volume (Units), by Segment, 2018-2033 81

7.5 Reversible Contraceptive Devices Market, United States, Average Price ($), 2018-2033 83

7.6 Reversible Contraceptive Devices Market, United States, Distribution Share by Revenue ($m), 2018-2033 84

7.7 Reversible Contraceptive Devices Market, United States, Company Share by Revenue ($m), 2023 85

8 Overview of Key Companies in United States, Reproductive Health Devices Market 87

8.1 Organon 87

8.1.1 Company Overview 87

8.2 Bayer AG 87

8.2.1 Company Overview 87

8.3 CooperSurgical Inc 87

8.3.1 Company Overview 87

8.4 Allergan Aesthetics 87

8.4.1 Company Overview 87

8.5 Hologic Inc 88

8.5.1 Company Overview 88

8.6 Cook Medical LLC 88

8.6.1 Company Overview 88

9 Reproductive Health Devices Market Pipeline Products 89

10 Financial Deals Landscape 90

10.1 Acquisition 90

10.1.1 Arbor Biotech Acquires Serendipity Bio 90

10.2 Asset Transactions 91

10.2.1 Celularity Acquires Rebound Product from Sequence Lifescience 91

10.2.2 Drive DeVilbiss Healthcare Acquires Portfolio of Products from Mobility Designed 92

10.3 Partnerships 93

10.3.1 Exact Sciences Enters into Licensing Agreement with TwinStrand Biosciences 93

10.4 Venture Financing 94

10.4.1 3Daughters Raises Additional USD4.7 Million in Seed Financing 94

11 Recent Developments 96

11.1 Corporate Communications 96

11.1.1 Feb 14, 2025: Scott Sutton Elected to Celanese Board of Directors 96

11.1.2 Dec 19, 2024: Christopher Kuehn Elected to Celanese Board of Directors 96

11.1.3 Dec 09, 2024: Celanese Announces Leadership Transition 97

11.1.4 Dec 09, 2024: Celanese Announces Leadership Transition 97

11.1.5 Sep 06, 2024: Celanese Elects Bruce Chinn to Board of Directors 98

11.1.6 Jun 24, 2024: NN Announces Chris Bohnert as Chief Financial Officer 98

11.2 Financial Announcements 99

11.2.1 Oct 07, 2024: Celanese to Hold Third Quarter Earnings Conference Call on November 5, 2024 99

11.2.2 Aug 01, 2024: Celanese Reports Second Quarter Earnings 99

11.2.3 Jul 02, 2024: Celanese to Hold Second Quarter Earnings Conference Call on August 2, 2024 101

11.3 Government and Public Interest 101

11.3.1 Oct 09, 2024: Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference 101

11.4 Other Significant Developments 101

11.4.1 May 10, 2024: Canadian Armed Forces Selects Delta Development Team to Enhance Frontline Medical Capacity 101

11.5 Product News 102

11.5.1 Nov 07, 2024: Northeastern University : IUDs Still ‘Very Safe’ in Light of New Research on Breast Cancer Risk 102

11.6 Strategy And Business Planning 103

11.6.1 Apr 09, 2025: IVI RMA North America Announces Partnership With TMRW Life Sciences 103

11.6.2 Mar 13, 2025: Nabla Announces New Partnership With Tia 103

11.6.3 Jan 22, 2025: Baird Medical Expands Into San Francisco, Advancing U.S. Market Growth 104

12 Appendix 105

12.1 Research Methodology 106

12.1.1 Coverage 106

12.1.2 Secondary Research 106

12.1.3 Primary Research 107

12.1.4 Market Modeling and Forecasting 108

12.1.5 Company Share Analysis 109

12.1.6 Distribution Share Analysis 109

12.1.7 Benchmarking 110

12.2 GlobalData Consulting 110

12.3 Contact Us 110

12.4 Disclaimer 111

Table

Table 1: Reproductive Health Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 15

Table 2: Reproductive Health Devices Market, United States, Category Contribution by Revenue ($m), 2023 18

Table 3: Reproductive Health Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 20

Table 4: Reproductive Health Devices Market, United States, Volume (Units), 2018-2033 22

Table 5: Reproductive Health Devices Market, United States, Volume (Units), 2018-2033 24

Table 6: Reproductive Health Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023 27

Table 7: Assisted Reproductive Technology (ART) Devices Market, United States, Segment Contribution (%), 2023 30

Table 8: Assisted Reproductive Technology (ART) Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 32

Table 9: ART Media Market, United States, Revenue ($m), USD Constant, 2018-2033 34

Table 10: ART Micropipettes Market, United States, Revenue ($m), USD Constant, 2018-2033 36

Table 11: Assisted Reproductive Technology (ART) Devices Market, United States, Volume (Units), 2018-2033 38

Table 12: ART Media Market, United States, Volume (Units), 2018-2033 41

Table 13: ART Micropipettes Market, United States, Volume (Units), 2018-2033 44

Table 14: Assisted Reproductive Technology (ART) Devices Market, United States, Average Price ($), 2018-2033 45

Table 15: Assisted Reproductive Technology (ART) Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018-2033 47

Table 16: Assisted Reproductive Technology (ART) Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023 49

Table 17: Endometrial Ablation Devices Market, United States, Segment Contribution (%), 2023 52

Table 18: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 54

Table 19: Endometrial Ablation Devices Market, United States, Volume (Units), 2018-2033 56

Table 20: Endometrial Ablation Devices Market, United States, Average Price ($), 2018-2033 57

Table 21: Endometrial Ablation Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018-2033 58

Table 22: Endometrial Ablation Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023 60

Table 23: Female Sterilization Devices Market, United States, Segment Contribution (%), 2023 63

Table 24: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 65

Table 25: Female Sterilization Devices Market, United States, Volume (Units), 2018-2033 67

Table 26: Female Sterilization Devices Market, United States, Average Price ($), 2018-2033 68

Table 27: Female Sterilization Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018-2033 69

Table 28: Female Sterilization Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023 71

Table 29: Reversible Contraceptive Devices Market, United States, Segment Contribution (%), 2023 74

Table 30: Reversible Contraceptive Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 76

Table 31: Intrauterine Devices (IUDs) Market, United States, Revenue ($m), USD Constant, 2018-2033 78

Table 32: Reversible Contraceptive Devices Market, United States, Volume (Units), 2018-2033 80

Table 33: Intrauterine Devices (IUDs) Market, United States, Volume (Units), 2018-2033 82

Table 34: Reversible Contraceptive Devices Market, United States, Average Price ($), 2018-2033 83

Table 35: Reversible Contraceptive Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018-2033 84

Table 36: Reversible Contraceptive Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023 86

Table 37: Reproductive Health Devices Market Pipeline Products 89

Table 38: Arbor Biotech Acquires Serendipity Bio 90

Table 39: Celularity Acquires Rebound Product from Sequence Lifescience 91

Table 40: Drive DeVilbiss Healthcare Acquires Portfolio of Products from Mobility Designed 92

Table 41: Exact Sciences Enters into Licensing Agreement with TwinStrand Biosciences 93

Table 42: 3Daughters Raises Additional USD4.7 Million in Seed Financing 94

Table 43: Total Number of Primary Research Participants, Reproductive Health Devices Market, by Country 107

Figures

Figure 1: Reproductive Health Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 14

Figure 2: Reproductive Health Devices Market, United States, Revenue Mix ($m), 2023 16

Figure 3: Reproductive Health Devices Market, United States, Category Contribution (%), 2023 17

Figure 4: Reproductive Health Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 19

Figure 5: Reproductive Health Devices Market, United States, Volume (Units), 2018-2033 21

Figure 6: Reproductive Health Devices Market, United States, Volume (Units), 2018-2033 23

Figure 7: Reproductive Health Devices Market, United States, Company Share (%) 2023 26

Figure 8: Assisted Reproductive Technology (ART) Devices Market, United States, Revenue Mix ($m), 2023 28

Figure 9: Assisted Reproductive Technology (ART) Devices Market, United States, Segment Contribution (%), 2023 29

Figure 10: Assisted Reproductive Technology (ART) Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 31

Figure 11: ART Media Market, United States, Revenue ($m), USD Constant, 2018-2033 33

Figure 12: ART Micropipettes Market, United States, Revenue ($m), USD Constant, 2018-2033 35

Figure 13: Assisted Reproductive Technology (ART) Devices Market, United States, Volume (Units), 2018-2033 37

Figure 14: ART Media Market, United States, Volume (Units), 2018-2033 40

Figure 15: ART Micropipettes Market, United States, Volume (Units), 2018-2033 43

Figure 16: Assisted Reproductive Technology (ART) Devices Market, United States, Company Share (%) 2023 48

Figure 17: Endometrial Ablation Devices Market, United States, Revenue Mix ($m), 2023 50

Figure 18: Endometrial Ablation Devices Market, United States, Segment Contribution (%), 2023 51

Figure 19: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 53

Figure 20: Endometrial Ablation Devices Market, United States, Volume (Units), 2018-2033 55

Figure 21: Endometrial Ablation Devices Market, United States, Company Share (%) 2023 59

Figure 22: Female Sterilization Devices Market, United States, Revenue Mix ($m), 2023 61

Figure 23: Female Sterilization Devices Market, United States, Segment Contribution (%), 2023 62

Figure 24: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 64

Figure 25: Female Sterilization Devices Market, United States, Volume (Units), 2018-2033 66

Figure 26: Female Sterilization Devices Market, United States, Company Share (%) 2023 70

Figure 27: Reversible Contraceptive Devices Market, United States, Revenue Mix ($m), 2023 72

Figure 28: Reversible Contraceptive Devices Market, United States, Segment Contribution (%), 2023 73

Figure 29: Reversible Contraceptive Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 75

Figure 30: Intrauterine Devices (IUDs) Market, United States, Revenue ($m), USD Constant, 2018-2033 77

Figure 31: Reversible Contraceptive Devices Market, United States, Volume (Units), 2018-2033 79

Figure 32: Intrauterine Devices (IUDs) Market, United States, Volume (Units), 2018-2033 81

Figure 33: Reversible Contraceptive Devices Market, United States, Company Share (%) 2023 85

United States (US) Reproductive Health Devices Market Outlook to 2033: Assisted Reproductive Technology (ART) Devices, Reversible Contraceptive Devices and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

United States (US) Reproductive Health Devices Market Outlook to 2033: Assisted Reproductive Technology (ART) Devices, Reversible Contraceptive Devices and Others was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Reproductive Health Devices reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States (US) Reproductive Health Devices Market Outlook to 2033: Assisted Reproductive Technology (ART) Devices, Reversible Contraceptive Devices and Others in real time.

  • Access a live United States (US) Reproductive Health Devices Market Outlook to 2033: Assisted Reproductive Technology (ART) Devices, Reversible Contraceptive Devices and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more